Suchergebnisse - "Swoboda, David M"

PubPharm (22)

1

Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)

enthalten in: Leukemia research | 2023

von Mangaonkar, A. | Swoboda, D. | Lasho, T. | +6

2

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

enthalten in: Blood cancer discovery | 2022

von Saini, N. | Swoboda, D. | Greenbaum, U. | +36

CommentIn: Blood Cancer Discov. 2022 Sep 6;3(5):382-384. - PMID 35896010

3

Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia : Is the combination indeed better?

enthalten in: American journal of hematology | 2022

von Ball, S. | Jain, A. | Aguirre, L. | +10

4

Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts

enthalten in: Leukemia | 2022

von Swoboda, D. | Kanagal-Shamanna, R. | Brunner, A. | +18

5

Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia : Is the combination indeed better?

enthalten in: American Journal of Hematology | 2022

von Ball, S. | Jain, A. | Aguirre, L. | +10

6

Genomic stratification of myelodysplastic/myeloproliferative neoplasms, unclassifiable : Sorting through the unsorted

enthalten in: Leukemia | 2021

von Mangaonkar, A. | Swoboda, D. | Lasho, T. | +6

7

Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy

enthalten in: Leukemia research | 2021

von Hunter, A. | Al Ali, N. | Mai, A. | +9

8

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

enthalten in: bioRxiv.org | 2021

von Saini, N. | Swoboda, D. | Greenbaum, U. | +30

9

Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Gesiotto, Q. | Swoboda, D. | Shallis, R. | +10

10

Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Shallis, R. | Bewersdorf, J. | Swoboda, D. | +12